Petascale, GPU, and cloud computing are transforming computer-aided drug design (CADD) into an even more powerful tool for both medical and basic-science research. The mission of the Durrant lab at the University of Pittsburgh is to develop broadly applicable, innovative CADD techniques. We use these techniques to further early-stage drug discovery targeting infectious diseases, neurological conditions, and cancer. The biologically active molecules we identify also serve as small-molecule probes that shed light on protein functions in cells. Click here to learn more about our research.